US EditionEight-year data “encouraging” for aortic valves using Resilia tissue technology - Cardiovascular News
Summary by Cardiovascular News
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.1 Articles
1 Articles
All
Left
Center
Right
Eight-year data “encouraging” for aortic valves using Resilia tissue technology - Cardiovascular News
Edwards Lifesciences has announced new eight-year data showing that patients receiving aortic surgical valves treated with its proprietary Resilia tissue technology have significantly improved long-term outcomes compared to those receiving non-Resilia tissue bioprosthetic valves. Presented at the Heart Valve Society annual meeting (16–19 April, Cairo, Egypt), the study of 947 patients marks the first long-term, propensity-matched comparison betw…
Coverage Details
Total News Sources1
Leaning Left0Leaning Right0Center0Last UpdatedBias DistributionNo sources with tracked biases.
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage
